Daily Oncology News

SABCS: Novel breast cancer drugs show promise in early trials

SABCS: Novel breast cancer drugs show promise in early trials

Pictilisib and pembrolizumab may prolong survival for women with advanced breast cancer, according to data from preliminary studies.

SABCS: Male breast cancer prognosis falls behind that for women

SABCS: Male breast cancer prognosis falls behind that for women

Although survival in male breast cancer has improved, treatment lags behind when compared to the cancer therapy women receive.

Utilizing home therapy for cancer-related lymphedema can lower costs

Utilizing home therapy for cancer-related lymphedema can lower costs

Home use of pneumatic compression devices to treat lymphedema can reduce annual treatment costs.

Mortality rates not increased in pregnancy-associated malignant melanoma

Mortality rates not increased in pregnancy-associated malignant melanoma

Cause-specific mortality similar for women and girls with pregnancy-associated MM or non-PAMM.

SABCS: Combined therapy can help younger breast cancer patients

SABCS: Combined therapy can help younger breast cancer patients

Adding tamoxifen to ovarian suppression doesn't provide a significant benefit over tamoxifen alone among premenopausal women with hormone receptor-positive early breast cancer, but the addition of ovarian suppression does benefit some of these women.

Many breast cancer patients overtreated with radiation therapy

Many breast cancer patients overtreated with radiation therapy

Two-thirds of breast-conserving surgical patients undergo six to seven weeks of radiation, but three weeks of higher-dose radiation could be more beneficial.

ASH: Carfilzomib increases survival in relapsed multiple myeloma

ASH: Carfilzomib increases survival in relapsed multiple myeloma

Improved progression-free survival in relapsed multiple myeloma has been seen with the addition of carfilzomib to lenalidomide and dexamethasone therapy.

Inherited mutations typical in triple-negative breast cancer

Inherited mutations typical in triple-negative breast cancer

Deleterious mutations were identified in 14.6 percent of patients in a cohort unselected for family history.

Prolonged TV watching may lower colorectal cancer survival chances

Prolonged TV watching may lower colorectal cancer survival chances

Researchers also found exercising seven hours or more a week boosted chances of living longer, whereas watching too much TV had the opposite effect.

Cognitive behavioral therapy for insomnia benefits cancer survivors

Cognitive behavioral therapy for insomnia benefits cancer survivors

Significant and durable improvements in insomnia and sleep quality, with and without armodafinil

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs